Why the study?
Does screening for hypertrophic cardiomyopathy prevent sudden death in young competitive athletes?
Does screening for hypertrophic cardiomyopathy prevent sudden death in young competitive athletes?
Screening and disqualification of affected young competitive athletes may prevent sudden death, despite hypertrophic cardiomyopathy being an uncommon cause of mortality in this group.
Answers are grounded in this paper and cite their sources.
HCM screening in athletes may still merit consideration; leaves open its net impact on sudden death prevention in this population.
The results show that hypertrophic cardiomyopathy was an uncommon cause of death in these young competitive athletes and suggest that the identification and disqualification of affected athletes at screening before participation in competitive sports may have prevented sudden death.
No takes yet. Share an insight, caveat, or question.
Corrado et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: